677713-07-4 Usage
General Description
2,6-Dimethylbenzoylacetonnitrile is a chemical compound that is commonly used in organic synthesis and pharmaceutical research. It is a colorless, crystalline solid with a faint odor, and its chemical formula is C11H11NO. 2,6-DIMETHYLBENZOYLACETONITRILE is known for its versatility as a building block in the synthesis of various biologically active molecules, including pharmaceuticals, agrochemicals, and other fine chemicals. Its unique structure allows it to participate in a wide range of reactions, making it a valuable tool for chemists in drug discovery and development. Additionally, 2,6-Dimethylbenzoylacetonnitrile is considered to be relatively stable and safe to handle, with a low potential for environmental harm.
Check Digit Verification of cas no
The CAS Registry Mumber 677713-07-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,7,7,1 and 3 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 677713-07:
(8*6)+(7*7)+(6*7)+(5*7)+(4*1)+(3*3)+(2*0)+(1*7)=194
194 % 10 = 4
So 677713-07-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H11NO/c1-8-4-3-5-9(2)11(8)10(13)6-7-12/h3-5H,6H2,1-2H3
677713-07-4Relevant articles and documents
ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR INHIBITORS
-
Page/Page column 62, (2010/04/03)
The present invention provides compounds and compositions, methods of making them, and methods of using them to modulate α7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can a
NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS
-
Page/Page column 46, (2008/12/07)
The present invention provides compounds of formula (I) and compositions thereof, methods of making them, and methods of using them to modulate alpha7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory system.
